Trimetazidine in the myocardial cell mechanisms of cytoprotection.
The experimental results demonstrate that TMZ displays the pharmacological characteristics of a "cytoprotective agent", since this drug exerts an anti-ischemic effect on myocardium totally independent of any hemodynamic changes.